Synektik Spólka Akcyjna (WSE:SNT)
273.00
+2.40 (0.89%)
At close: Dec 5, 2025
Synektik Spólka Akcyjna Revenue
Synektik Spólka Akcyjna had revenue of 199.24M PLN in the quarter ending September 30, 2025, with 41.16% growth. This brings the company's revenue in the last twelve months to 623.20M, up 0.73% year-over-year. In the fiscal year ending September 30, 2024, Synektik Spólka Akcyjna had annual revenue of 624.12M with 39.66% growth.
Revenue (ttm)
623.20M
Revenue Growth
+0.73%
P/S Ratio
3.74
Revenue / Employee
3.48M
Employees
179
Market Cap
2.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 624.12M | 177.25M | 39.66% |
| Sep 30, 2023 | 446.87M | 280.01M | 167.81% |
| Sep 30, 2022 | 166.86M | 38.23M | 29.72% |
| Sep 30, 2021 | 128.63M | 3.24M | 2.59% |
| Sep 30, 2020 | 125.39M | -9.40M | -6.97% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.30B |
| NEUCA | 13.34B |
| Voxel | 568.83M |
| Celon Pharma | 225.60M |
| Selvita | 373.90M |
| Ryvu Therapeutics | 90.41M |
| Centrum Medyczne ENEL-MED | 820.59M |
| Scope Fluidics | 718.00K |